Trent R. Hummel, MD
Title
Staff Physician
Appointment
Instructor of Clinical Pediatrics
Email
trent.hummel@cchmc.org
Phone
513-803-1126
Fax
513-636-3549
Credentials
BS: Eastern Mennonite University, 1997.
MD: University of Cincinnati College of Medicine, 2001.
Residency: Children’s Hospital Medical Center of Akron, Akron, Ohio, 2004.
Fellowship: Pediatric Hematology / Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, 2007; Research Fellow, Division of Experimental Hematology, Cincinnati Children’s Hospital Medical Center, 2008.
Certification: American Board of Pediatrics, 2004.
Awards and Honors
2007 - Procter Scholar Award, Cincinnati Children’s Hospital Medical Center
Publications, Most Recent
Hummel T, Hord J. Favorable Response to Soft Tissue Sarcoma Therapy in Adolescent with Embryonal Renal Sarcoma. Pediatr Blood Cancer 2004 July;43(1):70-2.
Presentations, Most Recent
Hummel T. Microarray Gene Expression Data Utilized to Identify Possible Serum Biomarkers of Neurofibromatosis type 1 Associated Tumors. American Society of Pediatric Hematology / Oncology, Annual Meeting 2008; Cincinnati, Ohio; May 14-17, 2008.
Hummel T. Microarray Gene Expression Data Utilized to Identify Possible Serum Biomarkers of Neurofibromatosis type 1 Associated Tumors. The Ohio State University’s Comprehensive Cancer Center 10th Annual Scientific Meeting; Columbus, Ohio; February 22, 2008.
Hummel T. Microarray Gene Expression Data Utilized to Identify Possible Serum Biomarkers of Neurofibromatosis type 1 Associated Tumors. Oncology Biomarkers: From Discovery to Validation; San Francisco, California;January 14-15, 2008.
Hummel T. Identification of NF biomarkers: ADM. Children’s Tumor Foundation, NF1 Microarray Consortium Meeting; June 9, 2007.
Hummel T. Microarray gene expression data utilized to identify possible serum biomarkers of Neurofibromatosis type 1. NF Conference 2007; Park City, Utah; June 10-13, 2007.
Professional Organization Memberships
Abstracts
Microarray Gene Expression Data Utilized to Identify Possible Serum Biomarkers of Neurofibromatosis type 1 Associated Tumors. American Society of Pediatric Hematology/Oncology. Annual Meeting 2008. Cincinnati, Ohio. May 14-17, 2008.
Microarry Gene Expression Data Utilized to Identify Possible Serum Biomarkers of Neurofibromatosis type 1 Associated Tumors. The Ohio State University's Comprehensive Cancer Center 10th Annual Scientific Meeting. Columbus, Ohio. February 22, 2008.
Microarray Gene Expression Data Utilized to Identify Possible Serum Biomarkers of Neurofibromatosis type 1 Associated Tumors. Oncology Biomarkers: From Discovery to Validation. San Francisco, CA. January 14-15, 2008.
Microarray Gene Expression Data Utilized to Identify Possible Serum Biomarkers of Neurofibromatosis type 1. NF Conference 2007, Park City, Utah. June 10-13, 2007.
